Gould, Harriet L., Amin, Kapish, Karategos, Thanos, Abbas, Sarah, Olive, Susannah, Sivananthan, Mathoorika, Rela, Ayeesha, Reed, Harriet, Powell, Catherine, Navaratnam, Janu, Ellis‐Owen, Rwth, Fielding, Patrick, Mondal, Dipanjali, Kihara, Steve, Williams, Gethin, Morgan, Carys, Witczak, Justyna, Cornish, Julie, Gwynne, Sarah, Horwood, James, Torkington, Jared, Hargest, Rachel ![]() ![]() |
![]() |
Khan, Mohid S., Srirajaskanthan, Raj, Frydman, Aviva and Pritchard, D. Mark 2024. Neuroendocrine tumours found at endoscopy: diagnosis and staging. Frontline Gastroenterology 16 (1) , pp. 51-58. 10.1136/flgastro-2023-102399 |
![]() |
Clift, Ash Kieran, Mahon, Hadley, Khan, Ghazanfar, Boardman-Pretty, Freya, Worker, Amanda, Marchini, Elena, Buendia, Orlando, Fish, Peter and Khan, Mohid S.
2024.
Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study.
British Journal of Cancer
131
, pp. 305-311.
10.1038/s41416-024-02736-1
![]() |
![]() |
Khan, Mohid ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Mandair, Dalvinder, Khan, Mohid S, Lopes, Andre, Furtado O'Mahony, Luke, Ensell, Leah, Lowe, Helen, Hartley, John A, Toumpanakis, Christos, Caplin, Martyn and Meyer, Tim 2021. Prognostic threshold for circulating tumor cells in patients with pancreatic and midgut neuroendocrine tumors. The Journal of Clinical Endocrinology & Metabolism 106 (3) , 872–882. 10.1210/clinem/dgaa822 |
![]() |
Cella, David, Evans, Jennifer, Feuilly, Marion, Neggers, Sebastian, Van Genechten, Dirk, Herman, Jackie and Khan, Mohid S. 2021. Patient and healthcare provider perspectives of first-generation somatostatin analogs in the management of neuroendocrine tumors and acromegaly: a systematic literature review. Advances in Therapy 38 (2) , 969–993. 10.1007/s12325-020-01600-x |
![]() |
Khan, Mohid S., Mellar, Katharina, Watts, Rupert, Bocher-Pianka, Isabelle, Majdi, Abdelali and Goldstein, Grace 2020. Patient survey of the physical, emotional, and informational challenges for patients living with neuroendocrine tumors. Oncology and Therapy 8 (1) , 67–80. 10.1007/s40487-019-00103-2 |
![]() |
Genus, Tracey S. E., Bouvier, Catherine, Wong, Kwok F., Srirajaskanthan, Rajaventhan, Rous, Brian A., Talbot, Denis C., Valle, Juan W., Khan, Mohid, Pearce, Neil, Elshafie, Mona, Reed, Nicholas S., Morgan, Eileen, Deas, Andrew, White, Ceri, Huws, Dyfed and Ramage, John 2019. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015. British Journal of Cancer 121 (11) , 966–972. 10.1038/s41416-019-0606-3 |
![]() |
Rizzo, Francesca M., Vesely, Clare, Childs, Alexa, Marafioti, Teresa, Khan, Mohid S., Mandair, Dalvinder, Cives, Mauro, Ensell, Leah, Lowe, Helen, Akarca, Ayse U., Luong, TuVinh, Caplin, Martyn, Toumpanakis, Christos, Krell, Daniel, Thirlwell, Christina, Silvestris, Franco, Hartley, John A. and Meyer, Tim 2019. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours. British Journal of Cancer 120 (3) , 294–300. 10.1038/s41416-018-0367-4 |
![]() |
Khan, Mohid S., Kirkwood, Amy A., Tsigani, Theodora, Lowe, Helen, Goldstein, Robert, Hartley, John A., Caplin, Martyn E. and Meyer, Tim 2016. Early changes in circulating tumor cells are associated with response and survival following treatment of metastatic neuroendocrine neoplasms. Clinical Cancer Research 22 (1) , 79–85. 10.1158/1078-0432.CCR-15-1008 |
![]() |